277 related articles for article (PubMed ID: 17683386)
1. Case of pemphigus foliaceus that shifted into pemphigus vulgaris after adrenal tumor resection.
Awazawa R; Yamamoto Y; Gushi M; Taira K; Yagi N; Asato Y; Hagiwara K; Uezato H
J Dermatol; 2007 Aug; 34(8):549-55. PubMed ID: 17683386
[TBL] [Abstract][Full Text] [Related]
2. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
Fukumoto T; Shiroyama Y; Niizeki H; Kobayashi N; Asada H; Ishii N; Hashimoto T; Miyagawa S
J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
[TBL] [Abstract][Full Text] [Related]
4. Neonatal pemphigus vulgaris.
Gushi M; Yamamoto Y; Mine Y; Awazawa R; Nonaka K; Taira K; Asato Y; Hagiwara K; Uezato H
J Dermatol; 2008 Aug; 35(8):529-35. PubMed ID: 18789074
[TBL] [Abstract][Full Text] [Related]
5. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
6. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
[TBL] [Abstract][Full Text] [Related]
8. Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?
Laffitte E; Panizzon RG; Borradori L
Dermatology; 2008; 217(4):337-9. PubMed ID: 18799879
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
11. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
Cirillo N; Santoro R; Lanza M; Annese P; Gombos F; Lanza A
Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
[TBL] [Abstract][Full Text] [Related]
12. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
[TBL] [Abstract][Full Text] [Related]
13. IgG/IgA pemphigus with dyskeratotic acantholysis and intraepidermal neutrophilic microabscesses.
Nakajima K; Hashimoto T; Nakajima H; Yokogawa M; Ikeda M; Kodama H
J Dermatol; 2007 Nov; 34(11):757-60. PubMed ID: 17973815
[TBL] [Abstract][Full Text] [Related]
14. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects and immunopathology in 48 patients with pemphigus].
Hahn K; Kippes W; Amagai M; Rzany B; Bröcker EB; Zillikens D
Hautarzt; 2000 Sep; 51(9):670-7. PubMed ID: 11057394
[TBL] [Abstract][Full Text] [Related]
16. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
Ishii K; Amagai M
Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
[TBL] [Abstract][Full Text] [Related]
17. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
[TBL] [Abstract][Full Text] [Related]
18. A Case of pemphigus foliaceus which occurred after five years of remission from pemphigus vulgaris.
Kimoto M; Ohyama M; Hata Y; Amagai M; Nishikawa T
Dermatology; 2001; 203(2):174-6. PubMed ID: 11586021
[TBL] [Abstract][Full Text] [Related]
19. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
20. Pemphigus with features of both vulgaris and foliaceus variants localized to the nose.
Mandel VD; Farnetani F; Vaschieri C; Manfredini M; Cesinaro AM; Giusti F; Pellacani G
J Dermatol; 2016 Aug; 43(8):940-3. PubMed ID: 26945696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]